Related Experiment Video
Updated: Jun 24, 2026
07:54
Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
Published on: December 21, 2019
Asbestos-induced lung diseases: an update.
1Department of Medicine, Northwestern University Feinberg School of Medicine and Jesse Brown VA Medical Center, Chicago, Ill 60611-3010, USA. d-kamp@northwestern.edu
Summary
Asbestos exposure causes lung diseases like asbestosis and cancer through poorly understood mechanisms. Recent research reveals new insights into asbestos pathogenicity and potential therapeutic targets for asbestos-related lung conditions.
Area of Science:
- Pulmonary Medicine
- Toxicology
- Oncology
Background:
- Asbestos exposure causes asbestosis and lung cancers (mesothelioma, bronchogenic carcinoma).
- Despite reduced use, asbestos-related lung diseases remain a concern due to historical use and long latency periods.
- Mechanisms underlying asbestos-induced lung damage are not fully understood.
Purpose of the Study:
- To review recent epidemiologic and pathogenic findings on asbestos-induced lung diseases.
- To highlight novel mechanistic pathways of asbestos lung injury.
- To discuss the translational significance for therapeutic strategies.
Main Methods:
- Review of recent epidemiologic studies on asbestos exposure and disease risk.
- Analysis of emerging pathogenic information on cellular and molecular mechanisms.
- Synthesis of data on alveolar epithelial cell injury, reactive oxygen species, apoptosis, and signaling pathways.
Main Results:
- Malignant transformation can occur with low-level asbestos exposure, unlike asbestosis.
- New mechanistic insights involve alveolar epithelial cell (AEC) injury and repair, iron-derived reactive oxygen species (ROS), and apoptosis.
- Key roles of cellular signaling pathways, cytokine/growth factor production, and epithelial-mesenchymal transition (EMT) are identified.
Conclusions:
- Understanding novel pathogenic pathways provides a molecular basis for treating asbestos-related lung diseases.
- These findings have implications for developing therapies for other pulmonary conditions like interstitial pulmonary fibrosis and lung cancer.
- Further research into AEC injury, ROS, apoptosis, and EMT is crucial for advancing treatment strategies.
Related Concept Videos
01:17Other Pulmonary Disorders
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:30Pleural Disorders: Types and Brief Description
The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:13Asthma III: Clinical Manifestations
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...